The Latest Breaking News from FDA

PHILADELPHIA -- The Food and Drug Administration urged food manufacturers last week to significantly reduce the amount of lead in processed baby food.

This month, the Food and Drug Administration approved a new drug, lecanemab, for the treatment of Alzheimer’s disease. The drug, sold under the brand name Leqembi, was developed by Japanese pharmaceutical company Eisai and will be marketed commercially in partnership with American pharmaceutical company Biogen. Biogen, notably, is the maker…

The Food and Drug Administration announced Friday a proposal to ease restrictions on blood donation by gay and bisexual men. The move was celebrated by LGBTQ rights advocates as “a tremendous leap forward toward elevating science over stigma.”

An FDA advisory committee recommended a major overhaul to how COVID shots are issued

Social media users shared a range of false claims this week

Several medical and LGBTQ groups have called the FDA's blood donor restrictions on gay men "discriminatory."

The U.S. is making it easier for gay and bisexual men to give blood by easing restrictions on groups that traditionally face higher risks of HIV

At a meeting to simplify the nation’s COVID-19 vaccination policy, the FDA’s panel of experts could agree on only one thing: Information is woefully lacking about how often different groups of Americans need to be vaccinated. That data gap has contributed to widespread skepticism, undervaccination, and ultimately unnecessary deaths from…

The first significant stage of post-Roe abortion litigation is underway and focuses heavily on abortion pills. GenBioPro, a pharmaceutical company that makes the drug mifepristone, has asked a federal court to declare that West Virginia’s anti-abortion law is inconsistent with the Federal Drug Administration’s determination that the pill is safe…